Trial reportHaematologica2023
Activity of decitabine combined with all-
Open access · goldAbstract readClinical Trial, Phase IILetter
In one paragraph
Trial report in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Decitabine plus all-Haematologica · 2026Trial
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 16 institutions in 1 country.
Christoph RummeltDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
Olga GrishinaClinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
Claudia SchmoorClinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
Martina CrysandtDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen University, Aachen.
Michael HeuserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover.
Katharina S GötzeDepartment of Medicine III, Technical University of Munich, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, München.
Richard F SchlenkDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; National Center of Tumor Diseases, NCT-Trial Center, German Cancer Research Center, Heidelberg.
Konstanze DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Helmut R SalihClinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tuebingen.
Gerhard HeilDepartment of Hematology/Oncology, Klinikum Luedenscheid, Luedenscheid.
Carsten Müller-TidowDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Heidelberg, Heidelberg, Germany; Department of Medicine A, University Hospital of Münster, Münster.
Wolfram BruggerDepartment of Hematology, Hospital Villingen-Schwenningen, Villingen-Schwenningen.
Andrea KündgenDepartment of Hematology, Oncology and Clinical Immunology, Heinrich- Heine-University, Faculty of Medicine, Düsseldorf, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Düsseldorf, Düsseldorf.
Maike De WitDepartment of Hematology and Oncology, Vivantes Klinikum Neukölln, Berlin.
Aristoteles GiagounidisClinic for Oncology, Hematology and Palliative Medicine, Marien-Hospital Düsseldorf, Düsseldorf.
Sebastian SchollDepartment of Hematology and Oncology, Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena.
Andreas NeubauerDepartment of Hematology and Oncology, University Clinic Gießen/Marburg, Marburg.
Jürgen KrauterDepartment of Internal Medicine III, Städtisches Klinikum Braunschweig, Braunschweig.
Gesine BugDepartment of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Frankfurt, Frankfurt.
Haifa Kathrin Al-AliKrukenberg Cancer Center, University Hospital Halle, Halle.
Ralph WäschDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
Heiko BeckerDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg.
Annette M MayInstitute for Surgical Pathology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg.
Justus DuysterDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg.
Björn HackansonDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Hematology/Oncology, Universitätsklinikum Augsburg, Augsburg.
Arnold GanserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover.
Hartmut DöhnerDepartment of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
Michael LübbertDepartment of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg. michael.luebbert@uniklinik-freiburg.de.
University Medical Center Freiburg · DEGerman Cancer Research Center · DEUniversity of Freiburg · DEMedizinische Hochschule Hannover · DEUniversity Hospital Heidelberg · DEJena University Hospital · DEKlinikum Braunschweig · DEKlinikum Lüdenscheid · DEMarien Hospital Düsseldorf · DENephrologisches Zentrum Villingen-Schwenningen · DERWTH Aachen University · DETechnical University of Munich · DEUniversitätsklinikum Gießen und Marburg · DEUniversity Hospital in Halle · DEUniversity Hospital Ulm · DEVivantes Klinikum · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsAzacitidineDecitabineHumansTretinoinAzacitidineDecitabineTretinoin
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.